Functional coding and non-coding variants in human BRCA1 gene and their use in genetic screening
- 3 July 2019
- journal article
- review article
- Published by Springer Nature in Medical Oncology
- Vol. 36 (8) , 71
Abstract
BRCA1 is involved in double-strand DNA damage repair pathways, and mutations in the gene are associated with hereditary breast and ovarian cancers. With great help of the development of high-throughput DNA sequencing techniques numerous single-nucleotide polymorphisms (SNPs) and insertion deletion (Indel) mutations are detected on both coding and non-coding/regulatory regions of the BRCA1. Mutations may cause pathogenic or benign changes on the protein function or affect its expression. In the last decade, use of genetic screening tests to detect mutations on such genes has become greatly popular. However, it is very important to know the effect of the detected mutations, which is mostly possible by the use of predictive softwares, and also the related family history to be able to correctly analyse the screening results and to inform the patient. Therefore, use of in silico and in vitro techniques to score the pathogenicity of detected variants on genes like BRCA1 is now of great importance. Otherwise, results obtained from screening tests and family history cannot be analysed precisely.Keywords
This publication has 24 references indexed in Scilit:
- Identification of fifteen novel germline variants in theBRCA13′UTR reveals a variant in a breast cancer case that introduces a functionalmiR-103target siteHuman Mutation, 2012
- SIFT web server: predicting effects of amino acid substitutions on proteinsNucleic Acids Research, 2012
- Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genesEuropean Journal of Human Genetics, 2011
- Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2Genetics in Medicine, 2010
- History and Current Status of Newborn Screening for HemoglobinopathiesSeminars in Perinatology, 2010
- The role of BRCA1 in DNA damage responseProtein & Cell, 2010
- Global Changes in Processing of mRNA 3′ Untranslated Regions Characterize Clinically Distinct Cancer SubtypesCancer Research, 2009
- Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53codon 72 Arg>Pro polymorphismBreast Cancer Research, 2007
- Results From The North Cyprus Thalassemia Prevention ProgramHemoglobin, 2007
- Tay-Sachs Disease Carrier Screening: A Model for Prevention of Genetic DiseaseGenetic Testing, 1998